| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $29.2M | $33.9M | $30.1M |
| YoY Revenue Growth % | -13.8% | +12.6% | — |
| Gross Profit | $7.5M | $8.9M | — |
| Gross Margin % | 25.7% | 26.3% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$15.7M | -$16.7M | -$28.2M |
| Operating Margin % | -53.6% | -49.3% | -80.0% |
| Net Income (GAAP) | -$17.0M | -$16.9M | -$27.7M |
| EBITDA (Normalized) | -$13.3M | -$15.3M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$8.7M | -$11.0M | -$16.1M |
| Capital Expenditures (CapEx) | $3.0M | $1.8M | — |
| Free Cash Flow (FCF) | -$11.7M | -$12.8M | -$16.1M |
| FCF Margin % | -40.0% | -37.7% | -53.4% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $2.6M | $4.5M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | -$22.3M | -$788.0K | — |